AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Analysts Upgrade CVS Health, Duolingo, ServiceTitan, Cogent Communications, and Sunrun.
ByAinvest
Monday, Aug 18, 2025 9:06 am ET1min read
Top Wall Street analysts upgraded several companies, including Duolingo, ServiceTitan, CVS Health, Cogent Communications, and Sunrun. Keybanc analyst Justin Patterson upgraded Duolingo from Sector Weight to Overweight, while Loop Capital analyst Yun Kim upgraded ServiceTitan from Hold to Buy. UBS analyst Kevin Caliendo upgraded CVS Health from Neutral to Buy, and Wells Fargo analyst Eric Luebchow upgraded Cogent Communications from Underweight to Overweight. RBC Capital analyst Christopher Dendrinos upgraded Sunrun from Sector Perform to Outperform.
Wall Street analysts have upgraded several companies, signaling optimism about their future performance. Keybanc analyst Justin Patterson upgraded Duolingo, Inc. (DUOL) from Sector Weight to Overweight, setting a $460 price target [1]. The stock closed at $326.93 on Friday. Loop Capital analyst Yun Kim upgraded ServiceTitan, Inc. (TTAN) from Hold to Buy, raising the price target from $100 to $140 [1]. ServiceTitan shares closed at $103.70 on Friday.UBS analyst Kevin Caliendo upgraded CVS Health Corporation (CVS) from Neutral to Buy, raising the price target from $67 to $79 [1]. CVS Health shares closed at $68.60 on Friday. Wells Fargo analyst Eric Luebchow upgraded Cogent Communications Holdings, Inc. (CCOI) from Underweight to Overweight, setting a $45 price target [1]. Cogent Comms shares closed at $34.25 on Friday.
RBC Capital analyst Christopher Dendrinos upgraded Sunrun Inc. (RUN) from Sector Perform to Outperform, boosting the price target from $12 to $16 [1, 3]. Sunrun shares closed at $13.92 on Friday. The upgrade reflects RBC's view that Sunrun deserves a multiple rerating due to increased certainty about long-term opportunities following treasury guidance clarification [3].
These upgrades suggest a positive outlook for these companies, with analysts expecting growth and improved performance. Investors should carefully consider these upgrades and their implications for each company's stock.
References:
[1] https://www.benzinga.com/analyst-stock-ratings/upgrades/25/08/47183958/this-cvs-health-analyst-turns-bullish-here-are-top-5-upgrades-for-monday
[3] https://www.investing.com/news/analyst-ratings/sunrun-stock-rating-upgraded-to-outperform-by-rbc-capital-on-itc-clarity-93CH-4196799
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet